, /PRNewswire/ -- Nevro Corp. (NYSE: ), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the second quarter of 2024 after the market closes on . The company will also host a conference call beginning at ( ) to discuss its financial results.
The live webcast and replay of the conference call will be available in the Investor Relations section of the company's website at . The webcast can be accessed 10 minutes prior to the conference call start time. For those parties that do not have internet access, the conference call can be accessed by calling one of the below telephone numbers and providing conference ID 9453183: Headquartered in , Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment.
The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary 10 kHz TherapyTM, an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 100,000 patients globally. Nevro's comprehensive HFXTM spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. Nevro recently added a minimally invasive treatment option for.
